Wnt1 Inducible Signaling Pathway Protein 1 (WISP1) Targets PRAS40 to Govern β-Amyloid Apoptotic Injury of Microglia

Author(s): Yan Chen Shang, Zhao Zhong Chong, Shaohui Wang, Kenneth Maiese

Journal Name: Current Neurovascular Research

Volume 9 , Issue 4 , 2012

Become EABM
Become Reviewer
Call for Editor


Given the present challenges to attain effective treatment for β-amyloid (Aβ) toxicity in neurodegenerative disorders such as Alzheimer’s disease, development of novel cytoprotective pathways that can assist immune mediated therapies through the preservation of central nervous system microglia could offer significant promise. We show that the CCN4 protein, Wnt1 inducible signaling pathway protein 1 (WISP1), is initially up-regulated by Aβ and can modulate its endogenous expression for the protection of microglia during Aβ mediated apoptosis. WISP1 activates mTOR and phosphorylates p70S6K and 4EBP1 through the control of the regulatory mTOR component PRAS40. Loss of PRAS40 through gene reduction or inhibition by WISP1 is cytoprotective. WISP1 ultimately governs PRAS40 by sequestering PRAS40 intracellularly through post-translational phosphorylation and binding to protein 14-3-3. Our work identifies WISP1, mTOR signaling, and PRAS40 as targets for new strategies directed against Alzheimer’s disease and related disorders.

Keywords: Alzheimer’s disease, amyloid, CCN4, microglia, mTOR, PRAS40, WISP1, novel cytoprotective pathways, renal fibroblasts, phosphatidylinositol-3-kinase

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 09 October, 2012
Page: [239 - 249]
Pages: 11
DOI: 10.2174/156720212803530618
Price: $65

Article Metrics

PDF: 5